Header cover image
  • Investing Ideas
  • Taiwanese Pharmaceuticals & Biotech High Return On Equity, Low Debt

Taiwanese Pharmaceuticals & Biotech High Return On Equity, Low Debt

Results

1

0 new

Stocks with a return on equity of over 30% and a debt to equity ratio below 1.

1 companies

Center Laboratories

Market Cap: NT$28.1b

A pharmaceutical company, develops, manufactures, and sells pharmaceuticals in Taiwan and internationally.

4123

NT$37.65

7D

-3.0%

1Y

2.9%